About George Hodgin
Form D filings for Biopharmaceutical Research from 2020 to 2023 list George Hodgin as chief executive officer and director.
George Hodgin first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name George Hodgin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people George Hodgin works with at each company, as listed on that company's latest Form D.
Biopharmaceutical Research Co · Form D, Aug 9, 2023